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Results: For the entire group median follow-up and overall 
survival (OS) were: 17.7 months (mo) (IQR: 10.3-27.9) and 
19.1 mo (95% CI 13.9-24.3). Median tBED for entire group was 
45.8 Gy (IQR 40.5-49) tBED in SD and ED group were 42.2 (IQR 
37.4-45.2) and 48.9 Gy (IQR 45.7-49.7) Univariate analysis by 
groups: Actuarial median OS: SD vs. ED was: 17 mo (95% CI 
13.6-20.3) vs. 22.3 mo (95% CI 9.6-35) p = 0.18. Actuarial 
median DFS SD vs. ED was: 8.3 (95% IC 7.2 – 9.3) vs. 12.8 mo 
(95% IC 3 – 22.7) p = 0.009. Actuarial median TPFS (mo) SD vs. 
ED was: 8.4 (95% CI 7.2-9.5) vs. 21.8 (95% CI 13.2-30.5) p = 
0.003.  
On multivariate analysis significant predictors for OS, DFS and 
TPFS are depicted on table: radiotherapy dose was found not 
to be a significant factor.  
 
 
 
Conclusion: On univariate analysis, but not on multivariate, 
ED associated statistically significant better DFS and TPFS 
and non-statistically significant better OS, even when 
adjusted to overall treatment time. Due to treatment time 
delays SD group received a suboptimal dose of radiotherapy 
and ED group received a tBED which virtually match nominal 
60 Gy. Our data in agreement with those resulting from 
randomized trials strongly support that 60 Gy @2 Gy with 
stringent control of time delays is the gold standard in the 
radiotherapy for NSCLC. 
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Purpose or Objective: Radiotherapy with or without 
chemotherapy is commonly used for isolated loco-regional 
recurrence of non-small cell lung cancer (NSCLC) after initial 
surgery. This study was undertaken to evaluate the outcomes 
and complications of curative radiotherapy for locoregionally 
recurrent NSCLC. 
 
Material and Methods: Medical records of 57 patients who 
received curative radiotherapy for locoregionally recurrent 
NSCLC without distant metastasis after surgery from 2004 to 
2014 were retrospectively reviewed. At the time of 
recurrence, the median age was 67 years (range 34-81 years), 
and most patients (84.2%) have good ECOG performance 
status. All patients initially received a curative intent 
operation, and the median disease-free interval was 14 
months. For locoregionally recurrent lung cancer, forty-two 
patients were treated with concurrent chemoradiotherapy 
(CCRT), and 15 patients with radiotherapy alone. Radiation 
dose ranged from 45 Gy to 70 Gy (median 66 Gy) by a three-
dimensional conformal technique. Lung function change after 
radiotherapy was evaluated by comparing pulmonary function 
tests before and after radiotherapy. 
 
Results: Median follow-up after recurrence was 20 months. 
Six patients showed a complete response, and 39 patients 
showed a partial response. The median survival was 30 
months. Two-year locoregional recurrence-free survival 
(LRFS), distant metastasis-free survival (DMFS), disease-free 
survival (DFS) and overall survival (OS) rate were 46.1%, 
37.2%, 31.9%, and 65.1%, respectively. Eleven patients 
showed disease progression within the radiation field after 
radiotherapy. Pulmonary function decreased meaningfully 
after radiotherapy, and radiation pneumonitis of any grade 
was seen in 19 patients. In the multivariate analysis, age 
under 70 years was associated with good OS (p=0.047); 
concurrent chemoradiotherapy with good OS (p=0.014), and 
DFS (p=0.003); and single-station recurrence with good OS 
(p=0.01), DFS (p=0.022), and LRFS (p=0.01). 
 
Conclusion: Patients who have locoregionally recurrent 
NSCLC showed favorable survival outcomes with salvage 
radiotherapy. However, lung function should be carefully 
evaluated before and after radiotherapy. Young age, single 
site recurrence, and the use of CCRT were good prognostic 
factors of overall survival. In patients with good prognostic 
factors and suitable for curative radiotherapy, CCRT could be 
considered to improve treatment outcomes. 
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Purpose or Objective: Precise delineation of primary lung 
cancer mass and involved mediastinal LN is very important 
requirement in order to improve radiotherapy outcome and 
minimize treatment toxicity. Diffusion weighted MRI (DW-
MRI) is a recently introduced functional imaging modality, 
having higher sensitivity and specificity than CT to 
differentiate lung cancer from post-obstructive lobar collapse 
. And also able to pinpoint lymph nodes with and without 
metastasis. The apparent diffusion coefficient (ADC) is the 
quantitative parameter of DW-MRI with cut off value 1.4 x 
103 mm2/s which can be used as a good tool to contour 
Target volumes in lung cancer. 
the aim is to study the feasibility of using the images of DW-
MRI and data of ADC map for radiotherapy contouring 
purposes 
 
Material and Methods: Twenty cases of newly diagnosed lung 
cancer patients underwent CT chest with contrast and 
respiratory gatted DW-MRI with b value of 0, 500, 1000s/mms 
. Both studies were obtained in the same position, respiratory 
phase and slice thickness (5mm) in order to allow proper 
image fusion. For each patient, we’ve delineated GTV for 
primary lung mass and GTV- LN for involved mediastinal LN 
on both CT scan (guided by size) and DW-MRI (guided by T2W 
and the ADC map ) together with delineation of the nearby 
risk structures. Auto margins were taken for the CTV and the 
PTV. The impact of using MRI on stage and different treated 
volumes was assessed and compared. 
 
 
